Brain 127(Pt 4):723734 Dalakas MC, Dagvadorj A, Goudeau B, Park KY, Takeda K, Simon-Casteras M, Vasconcelos O, Sambuughin N, Shatunov A, Nagle JW, Sivakumar K, Vicart P, Goldfarb LG (2003) Progressive skeletal myopathy, a phenotypic variant of desmin myopathy associated with desmin mutations
the per-component COA mass-spec data is the only direct status confirmation
Barragn JM, Rodriguez RE, Blzquez E
It would cost in the region of $20-30m, but it would hopefully tell you which diet helps people live longer
Evidence and NHS Treatments Ozempic (semaglutide) is a GLP-1 receptor agonist licensed in the UK exclusively for type 2 diabetes management, not for endometriosis treatment